{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:24:40Z","timestamp":1787837080097,"version":"build-2784847793"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002551","name":"Seoul National University","doi-asserted-by":"publisher","award":["New Faculty Startup Fund"],"award-info":[{"award-number":["New Faculty Startup Fund"]}],"id":[{"id":"10.13039\/501100002551","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015098","name":"Seoul Metropolitan Government Seoul National University Boramae Medical Center","doi-asserted-by":"publisher","award":["04-2023-0032"],"award-info":[{"award-number":["04-2023-0032"]}],"id":[{"id":"10.13039\/501100015098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002551","name":"Seoul National University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002551","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background &amp; aims<\/jats:title>\n                    <jats:p>Clonal hematopoiesis of indeterminate potential (CHIP) has emerged as a contributor to age-related diseases; however, its clinical relevance to metabolic liver disease remains to be established. This study investigated the association between CHIP and metabolic dysfunction-associated steatotic liver disease (MASLD) severity in a Korean biopsy cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a prospective analysis of 486 individuals who underwent liver biopsy and whole genome sequencing between 2014 and 2023. CHIP status was defined by pathogenic somatic mutations in known driver genes with a variant allele frequency \u22652%. Histological assessment was performed using the NASH-CRN scoring system. Logistic regression was used for cross-sectional associations, and Cox proportional hazards models were applied for fibrosis progression outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 427 eligible participants (median age 56\u00a0years), 37 (8.7%) harbored pathogenic CHIP mutation, predominantly\n                      <jats:italic>DNMT3A<\/jats:italic>\n                      (\n                      <jats:italic>n<\/jats:italic>\n                      =8) and\n                      <jats:italic>TET2<\/jats:italic>\n                      (\n                      <jats:italic>n<\/jats:italic>\n                      =6). CHIP prevalence did not differ significantly across histological categories: no steatotic liver disease (10.9%), metabolic dysfunction-associated steatotic liver (6.5%), and metabolic dysfunction-associated steatohepatitis (10.9%;\n                      <jats:italic>p<\/jats:italic>\n                      =0.269). No clinical or histological variable was consistently associated with CHIP across definitions in adjusted or unadjusted analyses.\u00a0Over a median 28-month follow-up, fibrosis progression occurred in 28 of 287 patients with serial assessments; no significant association with CHIP status was observed (HR 0.67, 95% CI 0.16\u20132.84;\u00a0\n                      <jats:italic>p<\/jats:italic>\n                      =0.582).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this biopsy-based cohort, CHIP was not significantly associated with hepatic histology severity or fibrosis progression. Given the limited number of CHIP carriers and progression events, clinically meaningful associations cannot be excluded and larger, longer-term longitudinal studies are warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12072-026-11143-y","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:14:25Z","timestamp":1787836465000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clonal hematopoiesis of indeterminate potential and metabolic dysfunction-associated steatotic liver disease: Korean biopsy cohort"],"prefix":"10.1007","author":[{"given":"Yun Kyu","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyungtai","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sae Kyung","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heejoon","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Hyeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Hwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keon Wook","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murim","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2926-1007","authenticated-orcid":false,"given":"Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Innovative Target Exploration of NAFLD (ITEN) consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"issue":"3","key":"11143_CR1","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","volume":"79","author":"VW Wong","year":"2023","unstructured":"Wong VW, Ekstedt M, Wong GL, Hagstr\u00f6m H. Changing epidemiology, global trends and implications for outcomes of NAFLD. J Hepatol. 2023;79(3):842\u2013852","journal-title":"J Hepatol"},{"issue":"6465","key":"11143_CR2","doi-asserted-by":"publisher","first-page":"eaan4673","DOI":"10.1126\/science.aan4673","volume":"366","author":"S Jaiswal","year":"2019","unstructured":"Jaiswal S, Ebert BL. Clonal hematopoiesis in human aging and disease. Science. 2019;366(6465):eaan4673","journal-title":"Science"},{"issue":"11","key":"11143_CR3","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.2337\/dc23-0805","volume":"46","author":"DK Tobias","year":"2023","unstructured":"Tobias DK, Manning AK, Wessel J, Raghavan S, Westerman KE, Bick AG, et al. Clonal Hematopoiesis of indeterminate potential (CHIP) and incident type 2 diabetes risk. Diabetes Care. 2023;46(11):1978\u20131985","journal-title":"Diabetes Care"},{"issue":"6327","key":"11143_CR4","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1126\/science.aag1381","volume":"355","author":"JJ Fuster","year":"2017","unstructured":"Fuster JJ, MacLauchlan S, Zuriaga MA, Polackal MN, Ostriker AC, Chakraborty R, et al. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science. 2017;355(6327):842\u2013847","journal-title":"Science"},{"issue":"2","key":"11143_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1701719","volume":"377","author":"S Jaiswal","year":"2017","unstructured":"Jaiswal S, Natarajan P, Silver AJ, Gibson CJ, Bick AG, Shvartz E, et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med. 2017;377(2):111\u2013121","journal-title":"N Engl J Med"},{"issue":"6","key":"11143_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.70173","volume":"6","author":"J Singh","year":"2025","unstructured":"Singh J, Li N, Ashrafi E, Thao LTP, Curtis DJ, Wood EM, et al. Factors Associated with risk of clonal haematopoiesis of indeterminate potential: a systematic review and meta-analysis. EJHaem. 2025;6(6): e70173","journal-title":"EJHaem"},{"issue":"8","key":"11143_CR7","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/s41588-022-01121-z","volume":"54","author":"SP Kar","year":"2022","unstructured":"Kar SP, Quiros PM, Gu M, Jiang T, Mitchell J, Langdon R, et al. Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis. Nat Genet. 2022;54(8):1155\u20131166","journal-title":"Nat Genet"},{"issue":"7958","key":"11143_CR8","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/s41586-023-05857-4","volume":"616","author":"WJ Wong","year":"2023","unstructured":"Wong WJ, Emdin C, Bick AG, Zekavat SM, Niroula A, Pirruccello JP, et al. Clonal haematopoiesis and risk of chronic liver disease. Nature. 2023;616(7958):747\u2013754","journal-title":"Nature"},{"issue":"4","key":"11143_CR9","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1097\/HEP.0000000000000839","volume":"80","author":"A Marchetti","year":"2024","unstructured":"Marchetti A, Pelusi S, Marella A, Malvestiti F, Ricchiuti A, Ronzoni L, et al. Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver disease. Hepatology. 2024;80(4):816\u2013827","journal-title":"Hepatology"},{"issue":"2","key":"11143_CR10","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jhep.2017.11.012","volume":"68","author":"D Schuppan","year":"2018","unstructured":"Schuppan D, Surabattula R, Wang XY. Determinants of fibrosis progression and regression in NASH. J Hepatol. 2018;68(2):238\u2013250","journal-title":"J Hepatol"},{"issue":"3","key":"11143_CR11","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/apt.17601","volume":"58","author":"YK Lee","year":"2023","unstructured":"Lee YK, Koo BK, Joo SK, Lee DH, Jang H, Chai JW, et al. Low-quality muscle mass rather than normal-quality muscle mass determines fibrosis progression in biopsy-proven NAFLD. Aliment Pharmacol Ther. 2023;58(3):322\u2013333","journal-title":"Aliment Pharmacol Ther"},{"key":"11143_CR12","doi-asserted-by":"crossref","unstructured":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024;81(3):492\u2013542","DOI":"10.1016\/j.jhep.2024.04.031"},{"issue":"1","key":"11143_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jhep.2016.08.019","volume":"66","author":"BK Koo","year":"2017","unstructured":"Koo BK, Kim D, Joo SK, Kim JH, Chang MS, Kim BG, et al. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis. J Hepatol. 2017;66(1):123\u2013131","journal-title":"J Hepatol"},{"issue":"7","key":"11143_CR14","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412\u2013419","journal-title":"Diabetologia"},{"key":"11143_CR15","doi-asserted-by":"crossref","unstructured":"Diagnosis and classification of diabetes: standards of care in diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S20-s42.","DOI":"10.2337\/dc24-S002"},{"issue":"5","key":"11143_CR16","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/ajg.2016.453","volume":"112","author":"S McPherson","year":"2017","unstructured":"McPherson S, Hardy T, Dufour JF, Petta S, Romero-Gomez M, Allison M, et al. Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis. Am J Gastroenterol. 2017;112(5):740\u2013751","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"11143_CR17","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.cgh.2022.02.026","volume":"21","author":"BK Koo","year":"2023","unstructured":"Koo BK, Lee H, Kwak SH, Lee DH, Park JH, Kim W. Long-term effect of PNPLA3 on the aggravation of nonalcoholic fatty liver disease in a biopsy-proven cohort. Clin Gastroenterol Hepatol. 2023;21(4):1105\u20137.e3","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"11143_CR18","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.cgh.2022.01.020","volume":"21","author":"YC Hsieh","year":"2023","unstructured":"Hsieh YC, Joo SK, Koo BK, Lin HC, Lee DH, Chang MS, et al. Myosteatosis, but not sarcopenia, predisposes NAFLD subjects to early steatohepatitis and fibrosis progression. Clin Gastroenterol Hepatol. 2023;21(2):388\u201397.e10","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"11143_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.cgh.2017.08.014","volume":"16","author":"D Kim","year":"2018","unstructured":"Kim D, Kim W, Joo SK, Bae JM, Kim JH, Ahmed A. Subclinical hypothyroidism and low-normal thyroid function are associated with nonalcoholic steatohepatitis and fibrosis. Clin Gastroenterol Hepatol. 2018;16(1):123\u201331.e1","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"11143_CR20","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/S1542-3565(05)00541-0","volume":"3","author":"TD Schiano","year":"2005","unstructured":"Schiano TD, Azeem S, Bodian CA, Bodenheimer HC Jr, Merati S, Thung SN, et al. Importance of specimen size in accurate needle liver biopsy evaluation of patients with chronic hepatitis C. Clin Gastroenterol Hepatol. 2005;3(9):930\u2013935","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"11143_CR21","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1136\/gutjnl-2020-321299","volume":"69","author":"J Neuberger","year":"2020","unstructured":"Neuberger J, Patel J, Caldwell H, Davies S, Hebditch V, Hollywood C, et al. Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology. Gut. 2020;69(8):1382\u20131403","journal-title":"Gut"},{"issue":"6","key":"11143_CR22","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313\u20131321","journal-title":"Hepatology"},{"issue":"9","key":"11143_CR23","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","volume":"94","author":"EM Brunt","year":"1999","unstructured":"Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94(9):2467\u20132474","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"11143_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-023-05292-2","volume":"24","author":"KA O\u2019Connell","year":"2023","unstructured":"O\u2019Connell KA, Yosufzai ZB, Campbell RA, Lobb CJ, Engelken HT, Gorrell LM, et al. Accelerating genomic workflows using NVIDIA Parabricks. BMC Bioinformatics. 2023;24(1): 221","journal-title":"BMC Bioinformatics"},{"key":"11143_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.12688\/f1000research.16665.2","volume":"9","author":"M Garcia","year":"2020","unstructured":"Garcia M, Juhos S, Larsson M, Olason PI, Martin M, Eisfeldt J, et al. Sarek: a portable workflow for whole-genome sequencing analysis of germline and somatic variants. F1000Res. 2020;9:63","journal-title":"F1000Res"},{"issue":"11","key":"11143_CR26","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1038\/s41591-021-01521-4","volume":"27","author":"A Niroula","year":"2021","unstructured":"Niroula A, Sekar A, Murakami MA, Trinder M, Agrawal M, Wong WJ, et al. Distinction of lymphoid and myeloid clonal hematopoiesis. Nat Med. 2021;27(11):1921\u20131927","journal-title":"Nat Med"},{"issue":"26","key":"11143_CR27","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","volume":"371","author":"G Genovese","year":"2014","unstructured":"Genovese G, K\u00e4hler AK, Handsaker RE, Lindberg J, Rose SA, Bakhoum SF, et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014;371(26):2477\u20132487","journal-title":"N Engl J Med"},{"issue":"26","key":"11143_CR28","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","volume":"371","author":"S Jaiswal","year":"2014","unstructured":"Jaiswal S, Fontanillas P, Flannick J, Manning A, Grauman PV, Mar BG, et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014;371(26):2488\u20132498","journal-title":"N Engl J Med"},{"issue":"21","key":"11143_CR29","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1158\/0008-5472.CAN-17-0337","volume":"77","author":"JT Robinson","year":"2017","unstructured":"Robinson JT, Thorvaldsd\u00f3ttir H, Wenger AM, Zehir A, Mesirov JP. Variant review with the integrative genomics viewer. Cancer Res. 2017;77(21):e31\u2013e34","journal-title":"Cancer Res"},{"issue":"D1","key":"11143_CR30","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate JG, Bamford S, Jubb HC, Sondka Z, Beare DM, Bindal N, et al. COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res. 2019;47(D1):D941\u2013D947","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"11143_CR31","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.031665","volume":"13","author":"H Tercan","year":"2024","unstructured":"Tercan H, Cossins BC, van Deuren RC, Rutten JHW, Joosten LAB, Netea MG, et al. Association between clonal hematopoiesis driver mutations, immune cell function, and the vasculometabolic complications of obesity. J Am Heart Assoc. 2024;13(2): e031665","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"11143_CR32","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3803\/EnM.2021.1337","volume":"37","author":"TJ Oh","year":"2022","unstructured":"Oh TJ, Song H, Koh Y, Choi SH. The presence of clonal hematopoiesis is negatively associated with diabetic peripheral neuropathy in type 2 diabetes. Endocrinol Metab. 2022;37(2):243\u2013248","journal-title":"Endocrinol Metab"},{"issue":"1","key":"11143_CR33","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1186\/s40001-025-02639-8","volume":"30","author":"C Zuo","year":"2025","unstructured":"Zuo C, Fu D, Huang Y, Li J, Yang S, Cheng X, et al. Association of clonal hematopoiesis of indeterminate potential with cardiometabolic multimorbidity progression and mortality: a prospective study of UK Biobank. Eur J Med Res. 2025;30(1):414","journal-title":"Eur J Med Res"},{"issue":"5","key":"11143_CR34","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018789","volume":"10","author":"B Haring","year":"2021","unstructured":"Haring B, Reiner AP, Liu J, Tobias DK, Whitsel E, Berger JS, et al. Healthy lifestyle and clonal hematopoiesis of indeterminate potential: results from the women\u2019s health initiative. J Am Heart Assoc. 2021;10(5): e018789","journal-title":"J Am Heart Assoc"},{"key":"11143_CR35","doi-asserted-by":"publisher","DOI":"10.1172\/JCI163968","author":"SK Pasupuleti","year":"2023","unstructured":"Pasupuleti SK, Ramdas B, Burns SS, Palam LR, Kanumuri R, Kumar R, et al. Obesity-induced inflammation exacerbates clonal hematopoiesis. J Clin Invest. 2023. https:\/\/doi.org\/10.1172\/JCI163968","journal-title":"J Clin Invest"},{"key":"11143_CR36","doi-asserted-by":"publisher","first-page":"1181879","DOI":"10.3389\/fpubh.2023.1181879","volume":"11","author":"MJ Kim","year":"2023","unstructured":"Kim MJ, Song H, Koh Y, Lee H, Park HE, Choi SH, et al. Clonal hematopoiesis as a novel risk factor for type 2 diabetes mellitus in patients with hypercholesterolemia. Front Public Health. 2023;11:1181879","journal-title":"Front Public Health"},{"key":"11143_CR37","doi-asserted-by":"publisher","DOI":"10.1172\/JCI197100","author":"B Yan","year":"2025","unstructured":"Yan B, Yuan Q, Buttigieg MM, Kaur P, McKee AR, Shabashvili DE, et al. Clonal hematopoiesis driven by Dnmt3a mutations promotes metabolic disease development in mice. J Clin Invest. 2025. https:\/\/doi.org\/10.1172\/JCI197100","journal-title":"J Clin Invest"},{"issue":"1","key":"11143_CR38","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13045-025-01740-z","volume":"18","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Cheng C. Racial disparities in clonal hematopoiesis and their impact on hematologic malignancies. J Hematol Oncol. 2025;18(1):88","journal-title":"J Hematol Oncol"},{"issue":"7","key":"11143_CR39","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1111\/cas.70406","volume":"117","author":"S Chi","year":"2026","unstructured":"Chi S, Motoike IN, Fujisawa T, Yamaguchi-Kabata Y, Nobukuni T, Kinoshita K, et al. Population-based identification of clonal hematopoiesis using peripheral blood whole-genome sequencing in Japan. Cancer Sci. 2026;117(7):1996\u20132006","journal-title":"Cancer Sci"},{"issue":"4","key":"11143_CR40","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3350\/cmh.2024.0562","volume":"30","author":"JH Bae","year":"2024","unstructured":"Bae JH. Racial and ethnic disparities in metabolic dysfunction-associated steatotic liver disease outcomes: a call for culturally sensitive interventions: editorial on \u201cDifferences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: a longitudinal real-world study.\u201d Clin Mol Hepatol. 2024;30(4):665\u2013668","journal-title":"Clin Mol Hepatol"},{"issue":"6","key":"11143_CR41","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.jhep.2020.02.020","volume":"72","author":"E Tr\u00e9po","year":"2020","unstructured":"Tr\u00e9po E, Valenti L. Update on NAFLD genetics: from new variants to the clinic. J Hepatol. 2020;72(6):1196\u20131209","journal-title":"J Hepatol"},{"issue":"1","key":"11143_CR42","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41423-020-00558-8","volume":"18","author":"Y Wen","year":"2021","unstructured":"Wen Y, Lambrecht J, Ju C, Tacke F. Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities. Cell Mol Immunol. 2021;18(1):45\u201356","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"11143_CR43","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nri.2017.11","volume":"17","author":"O Krenkel","year":"2017","unstructured":"Krenkel O, Tacke F. Liver macrophages in tissue homeostasis and disease. Nat Rev Immunol. 2017;17(5):306\u2013321","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"11143_CR44","doi-asserted-by":"publisher","first-page":"e20251114","DOI":"10.1084\/jem.20251114","volume":"223","author":"J Feng","year":"2026","unstructured":"Feng J, Wu B, Li Y, Sun P, Liu Q, Xiao Q, et al. Tet2 deficiency-induced expansion of monocyte-derived macrophages promotes liver fibrosis. J Exp Med. 2026;223(2):e20251114","journal-title":"J Exp Med."},{"issue":"10","key":"11143_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113164","volume":"42","author":"W Li","year":"2023","unstructured":"Li W, Yang Y, Yang L, Chang N, Li L. Monocyte-derived Kupffer cells dominate in the Kupffer cell pool during liver injury. Cell Rep. 2023;42(10): 113164","journal-title":"Cell Rep"},{"issue":"12","key":"11143_CR46","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.3324\/haematol.2018.215269","volume":"104","author":"AL Young","year":"2019","unstructured":"Young AL, Tong RS, Birmann BM, Druley TE. Clonal hematopoiesis and risk of acute myeloid leukemia. Haematologica. 2019;104(12):2410\u20132417","journal-title":"Haematologica"},{"issue":"10","key":"11143_CR47","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1038\/s41588-022-01179-9","volume":"54","author":"AS Nam","year":"2022","unstructured":"Nam AS, Dusaj N, Izzo F, Murali R, Myers RM, Mouhieddine TH, et al. Single-cell multi-omics of human clonal hematopoiesis reveals that DNMT3A R882 mutations perturb early progenitor states through selective hypomethylation. Nat Genet. 2022;54(10):1514\u20131526","journal-title":"Nat Genet"},{"issue":"8066","key":"11143_CR48","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41586-025-08938-8","volume":"642","author":"P Agarwal","year":"2025","unstructured":"Agarwal P, Sampson A, Hueneman K, Choi K, Jakobsen NA, Uible E, et al. Microbial metabolite drives ageing-related clonal haematopoiesis via ALPK1. Nature. 2025;642(8066):201\u2013211","journal-title":"Nature"},{"key":"11143_CR49","doi-asserted-by":"publisher","DOI":"10.1172\/JCI186423","author":"B Schnabl","year":"2025","unstructured":"Schnabl B, Damman CJ, Carr RM. Metabolic dysfunction-associated steatotic liver disease and the gut microbiome: pathogenic insights and therapeutic innovations. J Clin Invest. 2025. https:\/\/doi.org\/10.1172\/JCI186423","journal-title":"J Clin Invest"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-026-11143-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-026-11143-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-026-11143-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:14:27Z","timestamp":1787836467000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-026-11143-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":49,"alternative-id":["11143"],"URL":"https:\/\/doi.org\/10.1007\/s12072-026-11143-y","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"assertion":[{"value":"21 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Yun Kyu Lee, Hyungtai Sim, Sae Kyung Joo, Heejoon Jang, Dong Hyeon Lee, Jeong Hwan Park, Keon Wook Kang, Murim Choi, Won Kim have no conflicts of interest to disclose. The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Boramae Medical Center (IRB No. 16\u20132013-45), and all procedures were performed in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants, covering liver biopsy, whole genome sequencing, longitudinal clinical follow-up, and the secondary use of their clinical and genomic data for research.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies involving animal subjects.","order":3,"name":"Ethics","label":"Human and animal rights","group":{"name":"EthicsHeading","label":"Declarations"}}]}}